Omic.ai
PrivateCompany Overview
Omic.ai operates in Healthcare & Life Sciences and is based in Seattle, Washington. It was founded in 2017.
Omic.ai is a biotechnology company that provides an AI-driven digital patient and multi-omics drug discovery platform for target identification, biomarker discovery, and generative compound screening.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Revenue Share, Services & Consulting, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omic.ai Comparables
Compare Omic.ai with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insilico Medicine | 82% | |
| Cellworks Group Inc | 81% | |
| Deep Origin | 80% |
For institutional investors. Book with your work email.
Omic.ai Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 15, 2025
Grew 100% QoQ from 13 to 26 employees.
- Jan 17, 2025
Grew 100% QoQ from 12 to 24 employees.
For institutional investors. Book with your work email.
Omic.ai Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Omic.ai's valuation, stock price, and market status.
Is Omic.ai a public or private company?
Omic.ai is a private company.
What is the current stock price of Omic.ai?
Omic.ai is a private company, so its shares have no public market price. Caplight tracks Omic.ai's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Omic.ai worth (valuation)?
Valuation information for Omic.ai is not publicly available.
Can I buy Omic.ai stock?
Omic.ai shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Omic.ai's last funding round?
Funding round information for Omic.ai is not publicly available.
Who are the main investors in Omic.ai?
Investor information for Omic.ai is not publicly disclosed.
Will Omic.ai IPO soon?
No public IPO plans have been announced for Omic.ai.
How can I track Omic.ai secondary market activity?
Caplight tracks bids, offers, and trades in Omic.ai's shares on secondary markets.